Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets open in 7 hours 6 minutes

S&P Futures
5,965.75
+7.50(+0.13%)
Dow Futures
43,976.00
+75.00(+0.17%)
Nasdaq Futures
20,936.25
+42.25(+0.20%)
Russell 2000 Futures
2,409.20
+3.40(+0.14%)
Crude Oil
71.66
-0.03(-0.04%)
Gold
2,666.60
-9.70(-0.36%)

XTL Biopharmaceuticals Ltd. (XTLB)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD

Follow

Visitors trend2W10W9M

1.8100

-0.0100

(-0.55%)

At close: 04:00PM EST

1.8900

+0.08

(+4.42%)

After hours:

05:50PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	9.45M
Enterprise Value	7.11M
Trailing P/E	4.84
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	N/A
Price/Book (mrq)	3.65
Enterprise Value/Revenue	N/A
Enterprise Value/EBITDA	11.29

Trading Information

Stock Price History

Beta (5Y Monthly)	0.88
52-Week Change ³	114.12%
S&P500 52-Week Change ³	33.02%
52 Week High ³	4.9900
52 Week Low ³	0.7600
50-Day Moving Average ³	2.2972
200-Day Moving Average ³	2.1788

Share Statistics

Avg Vol (3 month) ³	40.66k
Avg Vol (10 day) ³	217.96k
Shares Outstanding ⁵	5.45M
Implied Shares Outstanding ⁶	5.45M
Float ⁸	487.72M
% Held by Insiders ¹	5.30%
% Held by Institutions ¹	2.09%
Shares Short (Oct 15, 2024) ⁴	14.67k
Short Ratio (Oct 15, 2024) ⁴	1.44
Short % of Float (Oct 15, 2024) ⁴	N/A
Short % of Shares Outstanding (Oct 15, 2024) ⁴	0.16%
Shares Short (prior month Sep 13, 2024) ⁴	9.7k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	Feb 10, 2017
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:5
Last Split Date ³	Feb 10, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Mar 31, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-13.78%
Return on Equity (ttm)	-13.07%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	N/A
Net Income Avi to Common (ttm)	-378k
Diluted EPS (ttm)	-0.0300
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	2.34M
Total Cash Per Share (mrq)	0
Total Debt (mrq)	N/A
Total Debt/Equity (mrq)	N/A
Current Ratio (mrq)	11.43
Book Value Per Share (mrq)	0.00

Cash Flow Statement

Operating Cash Flow (ttm)	N/A
Levered Free Cash Flow (ttm)	N/A